464 related articles for article (PubMed ID: 25994482)
21. Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer.
Liu C; Farah N; Weng W; Jiao B; Shen M; Fang L
Eur J Pharm Sci; 2019 Oct; 138():105009. PubMed ID: 31306781
[TBL] [Abstract][Full Text] [Related]
22. Glyceryl monooleyl ether-based liquid crystalline nanoparticles as a transdermal delivery system of flurbiprofen: characterization and in vitro transport.
Uchino T; Murata A; Miyazaki Y; Oka T; Kagawa Y
Chem Pharm Bull (Tokyo); 2015; 63(5):334-40. PubMed ID: 25948327
[TBL] [Abstract][Full Text] [Related]
23. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
24. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
Aggarwal G; Dhawan S; HariKumar SL
Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211
[TBL] [Abstract][Full Text] [Related]
25. Rapid pain relief using transdermal film forming polymeric solution of ketorolac.
Ammar HO; Ghorab M; Mahmoud AA; Makram TS; Ghoneim AM
Pharm Dev Technol; 2013; 18(5):1005-16. PubMed ID: 22191998
[TBL] [Abstract][Full Text] [Related]
26. Involvement of organic anion transport system in transdermal absorption of flurbiprofen.
Ito K; Kato Y; Tsuji H; Nguyen HT; Kubo Y; Tsuji A
J Control Release; 2007 Dec; 124(1-2):60-8. PubMed ID: 17884233
[TBL] [Abstract][Full Text] [Related]
27. Effect of olive oil on transdermal penetration of flurbiprofen from topical gel as enhancer.
Hussain A; Khan GM; Jan SU; Shah S; Shah K; Akhlaq M; Rahim N; Nawaz A; Wahab A
Pak J Pharm Sci; 2012 Apr; 25(2):365-9. PubMed ID: 22459463
[TBL] [Abstract][Full Text] [Related]
28. The effect of ion-pair formation combined with penetration enhancers on the skin permeation of loxoprofen.
Hui M; Quan P; Yang Y; Fang L
Drug Deliv; 2016 Jun; 23(5):1550-7. PubMed ID: 25386739
[TBL] [Abstract][Full Text] [Related]
29. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
[TBL] [Abstract][Full Text] [Related]
30. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
[TBL] [Abstract][Full Text] [Related]
31. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
Song A; Su Z; Li S; Han F
Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972
[TBL] [Abstract][Full Text] [Related]
32. Saturated long-chain esters of isopulegol as novel permeation enhancers for transdermal drug delivery.
Chen Y; Cun D; Quan P; Liu X; Guo W; Peng L; Fang L
Pharm Res; 2014 Aug; 31(8):1907-18. PubMed ID: 24449443
[TBL] [Abstract][Full Text] [Related]
33. Formulation and evaluation of flurbiprofen microemulsion.
Ambade KW; Jadhav SL; Gambhire MN; Kurmi SD; Kadam VJ; Jadhav KR
Curr Drug Deliv; 2008 Jan; 5(1):32-41. PubMed ID: 18220549
[TBL] [Abstract][Full Text] [Related]
34. Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
Rhee YS; Nguyen T; Park ES; Chi SC
Arch Pharm Res; 2013 May; 36(5):602-7. PubMed ID: 23475315
[TBL] [Abstract][Full Text] [Related]
35. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
[TBL] [Abstract][Full Text] [Related]
36. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis.
Khan D; Qindeel M; Ahmed N; Khan AU; Khan S; Rehman AU
Nanomedicine (Lond); 2020 Mar; 15(6):603-624. PubMed ID: 32098563
[No Abstract] [Full Text] [Related]
37. Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron.
Sun L; Cun D; Yuan B; Cui H; Xi H; Mu L; Chen Y; Liu C; Wang Z; Fang L
J Pharm Sci; 2012 Dec; 101(12):4540-8. PubMed ID: 22972714
[TBL] [Abstract][Full Text] [Related]
38. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
39. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
40. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment.
Abidin L; Mujeeb M; Imam SS; Aqil M; Khurana D
Drug Deliv; 2016; 23(3):1079-84. PubMed ID: 25116512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
